Development of a hydroxyflavone-labelled 4554W peptide probe for monitoring αS aggregation

Parkinson’s is the second most common neurodegenerative disease, with the number of individuals susceptible due to increase as a result of increasing life expectancy and a growing worldwide population. However, despite the number of individuals affected, all current treatments for PD are symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Watt, Kathryn J. C., Meade, Richard M., James, Tony D., Mason, Jody M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326036/
https://www.ncbi.nlm.nih.gov/pubmed/37414785
http://dx.doi.org/10.1038/s41598-023-37655-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326036/
https://www.ncbi.nlm.nih.gov/pubmed/37414785
http://dx.doi.org/10.1038/s41598-023-37655-3

Ejemplares similares